Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole-Reference-Cited by-同舟云学术

Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole

Published:2024-09 Issue: Volume:209 Page:114239
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Fasching Peter A.,Hack Carolin C.,Nabieva Naiba,Maass Nicolai,Aktas Bahriye,Kümmel Sherko,Thomssen Christoph,Wolf Christopher,Kolberg Hans-Christian,Brucker Cosima,Janni Wolfgang,Dall Peter,Schneeweiss Andreas,Marme Frederik,Sütterlin Marc W.,Ruebner Matthias,Theuser Anna-Katharin,Kellner Sara,Hofmann Nadine M.,Böhm Sybille,Almstedt Katrin,Lück Hans-Joachim,Schmatloch Sabine,Kalder Matthias,Uleer Christoph,Jurhasz-Böss Ingolf,Hanf Volker,Jackisch Christian,Müller Volkmar,Rack Brigitte,Belleville Erik,Wallwiener Diethelm,Rody Achim,Rauh Claudia,Bayer Christian M.,Uhrig Sabrina,Goossens Chloë,Huebner Hanna,Brucker Sara Y.,Hein Alexander,Fehm Tanja N.,Häberle Lothar

Funder

Novartis

Novartis Pharma GmbH

Publisher

Elsevier BV

Reference25 articles.

1. National Comprehensive Cancer Network (NCCN), NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Breast Cancer Version 3.2022. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf, 2022: p. accessed June 18, 2022.

2. AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021;Ditsch;Breast Care (Basel),2021

3. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Loibl;Ann Oncol,2024

4. Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update;Burstein;J Clin Oncol,2019

5. Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial;Goss;J Clin Oncol,2013